7月 2026ZYUS的市場佔有率分析

ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain...

行業: N/A

域名zyus.com

成立年份2018

僱員51 - 200

年度營收$15M - $25M

ZYUS

ZYUS（包含公司地區）

zyus.com

查看更多網站流量與參與度資訊

ZYUS截至 7月 2026 的總收入為 15M - 25M

ZYUS 熱門網域產生的總收入

ZYUS 熱門網域 3 年內的總收入

ZYUS 熱門網域的總收入

zyus.com15M - 25M

透過銷售情報查看更多內容

ZYUS的熱門網域總造訪量

了解ZYUS市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

zyus.com1.4K

透過銷售情報查看更多內容

ZYUS的熱門網域平均造訪時長

分析ZYUS參與度指標。

過去 3 個月平均造訪時長

子公司細目

zyus.com00:00:34

透過銷售情報查看更多內容

ZYUS的熱門網域平均頁面瀏覽量

了解ZYUS如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

zyus.com1.92

透過銷售情報查看更多內容

ZYUS按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術ZYUS

这些是ZYUS顶级域名使用的行业网站技术

轉換與分析 (4)

Google Analytics

小工具 (3)

reCAPTCHA

付費廣告 (2)

Google Adsense

電子郵件服務 (2)

Microsoft Exchange Online

更多技術

4

檢視所有

新聞與訊號來自ZYUS

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞ZYUS Life Sciences Inc. received financing of $89K in secured loan financing on Jul 29th '26.SASKATOON, SK, July 29, 2026 /CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, is pleased to announce that its wholly-owned subsidiary, ZYUS Life Sciences Inc. ("ZYUS Inc."), has closed a seventh tranche (the "Seventh Tranche") of a secured loan financing (the "Secured Loan") on July 29, 2026 with certain lenders (the "Lenders"), including an insider of the Company, for gross proceeds of CAD$125,000.

新聞ZYUS Life Sciences Inc. received financing of $187K in secured loan financing on May 27th '26.SASKATOON, SK, May 28, 2026 /CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, is pleased to announce that its wholly-owned subsidiary, ZYUS Life Sciences Inc. ("ZYUS Inc."), has closed a second tranche (the "Second Tranche") of a secured loan financing (the "Secured Loan") on May 27, 2026 with certain lenders (the "Lenders"), including certain insiders of the Company, for gross proceeds of CAD$265,000.

新聞ZYUS Life Sciences Inc. received financing of $131K in secured loan financing on May 20th '26.SASKATOON, SK, May 20, 2026 /CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, is pleased to announce that its wholly-owned subsidiary, ZYUS Life Sciences Inc. ("ZYUS Inc."), has closed a first tranche (the "First Tranche") of a secured loan financing (the "Secured Loan") on May 20, 2026 with certain lenders (the "Lenders"), including certain insiders of the Company, for gross proceeds of CAD$180,000.